health
Trump promotes study of psychedelics like LSD for mental health treatments
The President of the United States, Donald Trump, signed an executive order this Saturday to promote research into psychedelics such as LSD, psilocybin, and ibogaine as new treatment options for people with severe mental health disorders. The directive establishes new guidelines for the Food and Drug Administration (FDA) to expand [...]
TL;DR
- President Donald Trump signed an executive order to boost research into psychedelic drugs.
- The goal is to explore psychedelics as new treatment options for severe mental health disorders, including PTSD and traumatic brain injuries in veterans.
- The order directs the FDA to expand researchers' access to substances like LSD, psilocybin, and ibogaine in controlled therapeutic environments.
- It includes a commitment of approximately $50 million from existing Health Department funds to support states developing psychedelic programs.
- The order also mandates a review of the regulatory status of psychedelic substances that successfully complete phase 3 trials to potentially reclassify them for medical use.